Comparative genomic hybridization analysis of thymic neuroendocrine tumors

Modern Pathology

Volumn 18, Issue 3, 2005, Pages 358-364

  Pan, Chin Chen ^a,b   Jong, Yiin Jeng ^a   Chen, Yann Jang ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Carcinoid; CGH; MEN1; Thymic neuroendocrine tumor

Indexed keywords

ADULT; ARTICLE; CARCINOID; CHROMOSOME 11Q; CHROMOSOME 18; CHROMOSOME 20P; CHROMOSOME 3; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME 9Q; CHROMOSOME DELETION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE; GENE LOCATION; GENE LOCUS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEN1 GENE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RARE DISEASE; THYMOMA; X CHROMOSOME;

ADULT; AGED; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; NUCLEIC ACID HYBRIDIZATION; SURVIVAL ANALYSIS; THYMUS NEOPLASMS;

EID: 15444374948     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800246     Document Type: Article

References (40)

1. Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases. Cancer 1972;29:1061-1074.
2. Chaer R, Massad MG, Evans A, et al. Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 2002;74:1733-1740.
3. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000;114: 100-110.
4. Gal AA, Kornstein MJ, Cohen C, et al. Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study. Ann Thorac Surg 2001;72:1179-1182.
5. Rosai J. Histological Typing of Tumours of the Thymus 2nd edn. Springer-Verlag: New York: 1999.
6. Gibril F, Chen YJ, Schrump DS, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2003; 88:1066-1081.
7. Hessman O, Skogseid B, Westin G, et al. Multiple allelic deletions and intratumoral genetic heterogeneity in MEN1 pancreatic tumors. J Clin Endocrinol Metab 2001;86:1355-1361.
8. Teh BT, Zedenius J, Kytola S, et al. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 1998;228:99-105.
9. Yen CC, Chen YJ, Chen JT, et al. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001;92: 2769-2777.
10. Ullmann R, Petzmann S, Kiemen H, et al. The position of pulmonary carcinoids within the spectrum of neuroendocrine tumors of the lung and other tissues. Genes Chromosomes Cancer 2002;34:78-85.
11. Zhao J, de Krijger RR, Meier D, et al. Genomic alterations in well-differentiated gastrointestinal and bronchial neuroendocrine tumors (carcinoids): marked differences indicating diversity in molecular pathogenesis. Am J Pathol 2000;157:1431-1438.
12. Walch AK, Zitzelsberger HF, Aubele MM, et al. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 1998;153:1089-1098.
13. Chen YJ, Yeh SH, Chen JT, et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000;119:431-440.
14. Goto K, Kodama T, Matsuno Y, et al. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Mod Pathol 2001;14:985-994.
15. Debelenko LV, Swalwell JI, Kelley MJ, et al. MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma. Genes Chromosomes Cancer 2000;28: 58-65.
16. Petzmann S, Ullmann R, Klemen H, et al. Loss of heterozygosity on chromosome arm 11q in lung carcinoids. Hum Pathol 2001;32:333-338.
17. Jakobovitz O, Nass D, DeMarco L, et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab 1996;81: 3164-3167.
18. Onuki N, Wistuba II, Travis WD, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999;85:600-607.
19. Bale AE, Norton JA, Wong EL, et al. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1. Cancer Res 1991;51:1154-1157.
20. D'Adda T, Keller G, Bordi C, et al. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. Lab Invest 1999;79:671-677.
21. Debelenko LV, Emmert-Buck MR, Zhuang Z, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 1997;113:773-781.
22. Speel EJ, Richter J, Moch H, et al. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol 1999;155:1787-1794.
23. Stumpf E, Aalto Y, Hoog A, et al. Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer 2000;29:83-87.
24. Inoue M, Marx A, Zettl A, et al. Chromosome 6 suffers frequent and multiple aberrations in thymoma. Am J Pathol 2002;161:1507-1513.
25. Inoue M, Starostik P, Zettl A, et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res 2003;63:3708-3715.
26. Zhou R, Zettl A, Strobel P, et al. Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol 2001;159:1853-1860.
27. Kwong FM, Wong PS, Lung ML. Genetic alterations detected on chromosomes 13 and 14 in Chinese non-small cell lung carcinomas. Cancer Lett 2003;192: 189-198.
28. Michelland S, Gazzeri S, Brambilla E, et al. Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas. Cancer Genet Cytogenet 1999;114:22-30.
29. Trautmann K, Thakker RV, Ellison DW, et al. Chromosomal aberrations in sporadic pituitary tumors. Int J Cancer 2001;91:809-814.
30. Russell AJ, Sibbald J, Haak H, et al. Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage. Br J Cancer 1999;81: 684-689.
31. Hu J, Khanna V, Jones MM, et al. Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet Cytogenet 2002;139:18-23.
32. Renedo M, Martinez-Delgado B, Arranz E, et al. Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas. Leukemia 2001; 15:1627-1632.
33. Terracciano LM, Bernasconi B, Ruck P, et al. Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components. Hum Pathol 2003;34:864-871.
34. Brown CJ. Role of the X chromosome in cancer. J Natl Cancer Inst 1996;88:480-482.
35. Paulsson K, Fioretos T, Strombeck B, et al. Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies: a multicolor and locus-specific fluorescence in situ hybridization study. Cancer Genet Cytogenet 2003;140:66-69.
36. Afify A, Bland KI, Mark HF. Fluorescent in situ hybridization assessment of chromosome 8 copy number in breast cancer. Breast Cancer Res Treat 1996;38:201-208.
37. Bullerdiek J, Leuschner E, Taquia E, et al. Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet Cytogenet 1993;65:64-67.
38. Fujiwara Y, Monden M, Mori T, et al. Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res 1993;53: 857-860.
39. Yokota T, Yoshimoto M, Akiyama F, et al. Frequent multiplication of chromosomal region 8q24.1 associated with aggressive histologic types of breast cancers. Cancer Lett 1999;139:7-13.
40. Gal AA, Sheppard MN, Nolen JD, et al. p53, cellular proliferation, and apoptosis-related factors in thymic neuroendocrine tumors. Mod Pathol 2004;17:33-39.